BioDiscovery Releases Nexus Copy Number Version 5.0 for DNA Copy Number Analysis and Visualization
February 10, 2010
El Segundo, CA - BioDiscovery, Inc. a leader in integrated software solutions for microarray-based research, announced today the release of version 5 of its popular Nexus Copy Number software, the leading platform independent and user friendly application for DNA copy number analysis of microarray derived data. This latest version of Nexus Copy Number is a revolutionary step forward which expands on the number of unique and powerful analysis tools available in the software and includes a unique cloud-based database, called Nexus DB, for secure storage, cross project queries, and global collaboration. Some of the new features in Nexus Copy Number version 5 include a unique Survival Predictive Power tool allowing scientists to quickly and efficiently identify aberrant regions of the genome that have high degree of survival prediction accuracy. Additionally Nexus Copy Number can now directly import from and export data to the UCSC Genome Browser, simultaneously display probe level data for multiple samples in a single display, support Affymetrix CYCHP files, incorporate methylation data, and much more.
"Version 5 is a major new release for us that has been in development for close to a year and in beta use for many months. It offers many enhancements for data interpretation and deeper analysis as well as for augmenting collaborative work with data sharing through our new Nexus DB repository" said Dr. Soheil Shams, President of BioDiscovery. "Our user base continues to grow and many leading institutions are expanding their licenses as more individuals are discovering the ease and speed with which they can analyze their work using our software. With Nexus Copy Number version 5, we believe we are moving the bar even higher for a complete and powerful solution for rapid analysis of genomic changes."
Nexus Copy Number can integrate and process together, in a single project, data from commercial array platforms such as Agilent, Affymetrix, Illumina, Roche NimbleGen, as well as custom arrays. The software is applicable to many types of studies from focused projects of a cytogeneticist to large scale cancer studies. BioDiscovery is attuned to such different needs and offers the product in a flexible and modular system to allow users to create configurations that are suited to their needs.
About BioDiscovery, Inc.
BioDiscovery is a leader in the development of advanced microarray bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology.